-
Categories
-
Recent Posts
-
Recent Comments
Tags
CBI China conference CRO/Sponsor CROs data DIA diabetes drug development eClinical EDC EMA emerging region EU Europe European Medicines Agency facebook FDA India IT Kayda Norman Ken Getz Lisa Henderson London oncology Oracle patient/subject recruitment patients Peter O'Donnell Pfizer Pharmaceutical Executive Pharmaceutical Technology Philip Ward PRO Quintiles R&D Regulatory REMS Sites social media subject recruitment technology Tim Denman UK Wayne KubickJoin ACT for discussions, news, and more on
Category Archives: CRO/Sponsor
Take our Clinical Trial Feasibility Quiz
Take Our Survey!
polldaddy.add( {
type: 'iframe',
auto: true,
domain: '839289.polldaddy.com/s/',
id: 'clinical-trial-feasibility'
} );
Also posted in Regulatory, Sites Tagged clinical trial feasibility, industry standard research, ISR, quiz Leave a comment
Quicker Review for Generics and Biosimilars on the Horizon
The FDA’s review process for new drugs is slow. That is not news. But if a new agreement between the agency and the industry is approved by Congress things might get a little quicker.
UN-Administered Database
Collaboration between competitors is a growing trend in the clinical trial community. There have been numerous reports in the past few years of traditional rivals pooling their resources for the mutual benefit of both organizations.
Last week the AP reported a new twist on the concept, as eight drug makers entered into an agreement to share [...]
Posted in CRO/Sponsor Tagged collaboration, database, Tim Denman, tropical disease, UN Leave a comment
Did Someone Say Biotech?
Not just someone, but a lot of people. In conversations I’ve had with thought-leaders in the clinical trials space over the year, biotech companies are the place where growth will be seen for clinical trials. Even our own Advanstar Pharma/Science Editorial Director for Pharmaceutical Technology and BioPharm International Michelle Hoffman has indicated that biotech companies [...]
Also posted in IT Tagged Alan Louie, BioPharm International, biotech, CRO/Sponsor, eClinical, IDC Health Insights, INC Research, Jim Ogle, Lisa Henderson, Mchelle Hoffman, Pharmaceutical Technology Leave a comment
Facebook: Should I Stay Or Should I Go?
We like to be heard if we’re willing to listen. And yet, until now, pharmaceutical companies with a presence on Facebook have understandably been reluctant to “listen” by allowing consumers to post comments on their Facebook pages.
That changes on Monday, August 15, and the change leaves many pharma companies facing a dilemma. Most people agree [...]
Also posted in Regulatory Tagged facebook, FDA, News Feed, Omnicom Group, Pharmaceutical Executive, Regulatory, social media, technology, Thomas L. Harrison Leave a comment
Biosimilars Much to Learn and More to Come
There’s been much talk about biosimilars this year, and forecasts pin the global biosimilars market at $19.4 billion by 2014, growing at an expected CAGR of 89.1% between 2009 and 2014. The development costs for a single biosimilar molecule hovers between a large span of $50 million and $200 million.
So why all the attention? The [...]
Hiring Up for CROs and Services